Eric Venker, President & COO at Roivant Sciences Ltd. (ROIV), sold 2,000,000 shares at $11.22 ($22.3M) on 2025-06-03, disclosed to the SEC on 2025-06-04.
Seasonal sale ($22.3M) by President & COO — this insider has traded ROIV in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.07 | 433,722 | $4.8M | 21.5% |
| 2 | $11.07 | 433,722 | $4.8M | 21.5% |
| 3 | $11.22 | 566,278 | $6.4M | 28.5% |
| 4 | $11.22 | 566,278 | $6.4M | 28.5% |
| Total | $11.15 avg | 2,000,000 | $22.3M | 100% |
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |